Publications by authors named "Keith Massey"

Claim this Profile
A
Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2.
Maria Tolomeo, Valentina Magliocca, Stefania Petrini, Alessia Nisco, Roberto Barbaro, Keith Massey

Arch Biochem Biophys· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riboflavin supplementation in children with riboflavin transporter deficiency type 2 does not stop disease progression based on long-term follow-up.
Enrico Bertini, Keith Massey

Dev Med Child Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riboflavin transporter deficiency: gene therapy as a new therapeutic strategy.
Cecilia Mei, Valentina Magliocca, Xin Chen, Keith Massey, Anai Gonzalez-Cordero

Front Cell Neurosci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling riboflavin transporter deficiency type 2: from iPSC-derived motoneurons to iPSC-derived astrocytes.
Valentina Magliocca, Angela Lanciotti, Elena Ambrosini, Lorena Travaglini, Veronica D'Ezio, Keith Massey

Front Cell Neurosci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of natural mutations on the riboflavin transporter 2 and their relevance to human riboflavin transporter deficiency 2.
Lara Console, Maria Tolomeo, Jessica Cosco, Keith Massey, Maria Barile

IUBMB Life· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency.
Fiorella Colasuonno, Alessia Niceforo, Chiara Marioli, Anna Fracassi, Fabrizia Stregapede, Keith Massey

Oxid Med Cell Longev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency.
Alessia Niceforo, Chiara Marioli, Fiorella Colasuonno, Stefania Petrini, Keith Massey

Dis Model Mech· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells.
Chiara Marioli, Valentina Magliocca, Stefania Petrini, Alessia Niceforo, Rossella Borghi, Keith Massey

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Journey of Patients with Riboflavin Transporter Deficiency Type 2.
Fatima Amir, Carrie Atzinger, Keith Massey, John Greinwald, Lisa L Hunter

J Child Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis